Visa Senior Technical Product Manager With Bipolar Disorder Wins Florida MetLife LTD Insurance Appeal
MetLife terminated our client’s long-term disability benefits — despite her own treating psychiatrist confirming she could not work full time, part time, or in any modified work environment. MetLife’s hired reviewer simply disagreed, and that was enough for MetLife to cut her off.
Our client was a Senior Technical Product Manager at Visa Inc. in Florida, disabled by Bipolar I Disorder with rapid cycling, generalized anxiety disorder, and insomnia. This is a pattern we have seen in hundreds of bipolar disorder disability claims — the insurer acknowledges the diagnosis, acknowledges the symptoms, and then concludes the symptoms are not “severe enough” to prevent work. It is a conclusion built on selective reading, and we have beaten it over and over again.
We appealed and MetLife reversed its decision, reinstating our client’s benefits. Below, we break down exactly how MetLife tried to justify this denial, what its own records actually showed, and how our appeal dismantled every argument. If MetLife or any other disability insurance company has denied or terminated your benefits, speak with one of our long-term disability insurance lawyers for a free consultation. We represent claimants nationwide, and you pay nothing unless we recover your benefits.
Table of contents
- Why this case matters for every MetLife claimant
- MetLife’s denial: a paper review that ignored the treating psychiatrist’s own findings
- The medical evidence MetLife dismissed — and what it actually showed
- PHP/IOP treatment: the evidence MetLife used against our client
- The appeal: connecting psychiatric instability to occupational demands
- Medication intolerance as evidence of ongoing disability
- MetLife reverses its decision
- Denied by MetLife or another disability insurance company?
Why This Case Matters for Every MetLife Claimant
A treating doctor’s opinion that you cannot work does not protect you from a paper-review denial. If you are wondering whether MetLife can deny your disability claim when your own psychiatrist says you cannot work, the answer is yes — and that is exactly what happened here. Our client’s treating psychiatrist explicitly stated she was unable to work full time, part time, or in a modified work environment. MetLife’s IPC reviewer — a physician who never examined our client — overrode that opinion based on a file review. If your claim has been denied based on a paper review or independent medical examination, you need to understand how to challenge it.
Insurers will use your daily activities against you — even when those activities prove nothing about sustained work capacity. MetLife pointed to the fact that our client had been searching for jobs, going to interviews, and considering travel as evidence she could work. But looking for a job is not the same as performing a demanding, full-time technical management role day after day. Courts have consistently recognized this distinction, and our appeal made sure MetLife could not ignore it.
A gap in medical records is not evidence of recovery. After our client’s intensive outpatient program ended, MetLife argued that the absence of subsequent treatment records meant she had improved. The reality was that she had lost her insurance coverage and could not access the higher level of care her providers had recommended. The appeal documented that her symptoms never resolved — the records simply stopped because the access to care stopped.
Completing a treatment program does not mean you are ready to return to work. MetLife tried to treat our client’s discharge from a partial hospitalization and intensive outpatient program as a recovery milestone. But her discharge scores — a PHQ-9 of 16 and a GAD-7 of 21 — actually confirmed she remained moderately depressed and severely anxious at the time MetLife claimed she should be back at work.
Medication resistance is itself evidence of disability severity. Our client cycled through more than a half-dozen psychiatric medications, many producing intolerable side effects including muscle stiffness, brain fog, sedation, and manic activation. When an insurer argues that symptoms are not severe enough, a documented history of medication failure tells a different story entirely.
MetLife’s Denial: A Paper Review That Ignored the Treating Psychiatrist’s Own Findings
MetLife terminated our client’s long-term disability benefits through what the insurance industry calls an Independent Physician Consultation, or IPC — a paper review conducted by a physician who never met, examined, or spoke with the claimant. The termination letter, issued through Claims Specialist Micrin B., was built entirely on this IPC. An IPC is a file review in which a physician hired by the insurance company reads medical records and renders an opinion on whether restrictions and limitations are “warranted.” The physician never sees the patient, never observes their behavior, and never assesses their functional capacity in person.
MetLife’s IPC was conducted by a board-certified psychiatrist. The denial letter acknowledged the findings of our client’s treating psychiatrist across multiple visits. Those findings included:
- Restricted, depressed, anxious, and irritable mood and affect documented at every visit
- Decreased concentration and distractibility at every visit
- A Behavioral Health Assessment diagnosing generalized anxiety disorder, bipolar affective disorder, and insomnia
- Documented hopelessness, poor concentration with distractibility, mood swings, racing thoughts, panic attacks, crying spells, and low energy
- Moderately severe impairment in the ability to maintain appropriate emotional control, and severe-to-extreme impairment in emotional regulation
- An explicit endorsement that our client was “unable to work full time, part time, or in a modified work environment”
And yet, MetLife’s IPC reviewer concluded that “restrictions or limitations are not warranted.”
The Arguments MetLife Used to Override Its Own Evidence
MetLife’s denial letter relied on a series of arguments that, on closer inspection, contradicted the evidence in its own file. The denial stated that while her treating psychiatrist endorsed our client as unable to work, he “does not establish a severity of condition or symptomatology to preclude engagement in normal activity or in occupational activity.” This was a remarkable conclusion given that the same denial letter had just listed severe emotional impairment, distractibility, racing thoughts, panic attacks, and an inability to regulate emotions.
MetLife also cited the following as reasons to deny benefits:
- No suicidal or homicidal ideations — as if the absence of a crisis means the absence of a disability
- No psychosis and no problems with communication — criteria that have nothing to do with whether someone can sustain the cognitive demands of a complex technical management role
- Our client was “noted to be active in search for a new job while off work” — MetLife treated casual job searching as evidence of occupational capacity
- Mental status exams were “mostly unremarkable” apart from depressed mood, poor judgment, and attention deficits — MetLife minimized the very findings that support disability
- No referral to a higher level of care such as an Intensive Outpatient Program, Partial Hospitalization Program, or inpatient hospitalization
That last point was particularly misleading. A higher level of care had, in fact, been recommended — but our client’s insurance carrier would not authorize it unless outpatient treatment failed first. By the time escalation was warranted, she had lost her insurance coverage entirely. MetLife framed a systemic access-to-care barrier as evidence that her condition was not serious enough to require intensive treatment.
The Medical Evidence MetLife Dismissed — and What It Actually Showed
Bipolar I Disorder with rapid cycling is a chronic psychiatric condition characterized by intense mood episodes that alternate between depression and mania, often cycling over weeks rather than months. In practical terms, rapid cycling means the individual cannot sustain the emotional and cognitive stability required for consistent professional functioning — their mood, energy, concentration, judgment, and ability to regulate behavior can shift dramatically from one period to the next. For anyone asking whether bipolar disorder qualifies for long-term disability benefits, the medical literature is clear: research published in the Journal of Affective Disorders has confirmed that neurocognitive impairment in bipolar disorder is associated with significantly worse occupational functioning, even during periods when mood symptoms have partially remitted.
Our client’s medical record told a clear story of continuous psychiatric instability. From late 2024 through late 2025, nearly every clinical encounter documented objective abnormalities on mental status examination. The evidence came from multiple independent providers — psychiatrists, psychiatric nurse practitioners, and licensed professional counselors — all reaching the same conclusion: our client’s depression, anxiety, and bipolar symptoms remained significantly impairing.
The Depressive Phase: Severe Scores, Persistent Anxiety, Functional Collapse
When our client entered an intensive outpatient program for bipolar disorder, her initial psychiatric evaluation documented depression and anxiety at 7 out of 10, constricted affect, a thought content suggesting possible grandiosity, and standardized assessment scores that placed her squarely in the severe range. Her PHQ-9 score was 25 — the Patient Health Questionnaire-9 is a validated depression screening instrument scored from 0 to 27, and a score of 25 falls in the “severe depression” category, indicating pervasive depressive symptoms affecting nearly every aspect of daily functioning. Her GAD-7 score was 21 — the Generalized Anxiety Disorder-7 scale runs from 0 to 21, meaning our client scored at the maximum possible severity for anxiety.
Within days, her anxiety had escalated to a self-reported 20 out of 10, she was visibly anxious with a constricted and tearful affect throughout the evaluation, and she reported chronic suicidal ideation — a detail MetLife’s denial conspicuously failed to account for when arguing that the absence of suicidal ideation meant she was not severely impaired.
The Manic Phase: Impaired Judgment, Pressured Speech, Cognitive Disorganization
By mid-2025, the record shifted from depressive features to classic manic activation. Multiple therapy sessions documented expansive speech, expansive affect, upbeat but unstable mood, thought processes that were coherent but repetitive, and — critically — “judgment slightly impaired by mania, but exhibited logic.” These observations appeared across numerous visits, confirming a sustained manic phase rather than a transient episode.
The clinical significance of these findings cannot be overstated. A Senior Technical Product Manager at Visa — a position requiring precision, sustained concentration, rapid decision-making, emotional regulation, and intensive mental stamina — cannot function with impaired judgment, pressured speech, and repetitive thought patterns, even if the person appears “upbeat.” Mania is not wellness. It is a disabling component of bipolar disorder that compromises the very executive functions a high-level technical role demands. Research has consistently shown that cognitive impairment and sleep disruption in bipolar disorder are associated with significantly worse work performance, even in individuals whose mood symptoms appear to have partially stabilized.
The Cycle Continues: No Stabilization at Any Point
By fall of 2025, the record documented yet another shift — this time back toward depression following medication changes. Therapy notes from this period described tearful affect, low mood, impaired appetite related to medication adjustments, and persistent sleep impairment associated with bipolar disorder. At no point across the entire timeline — from late 2024 through late 2025 — was there a period of sustained clinical stability. The record showed cycling: severe depression, followed by anxiety and emotional dysregulation, followed by manic activation with impaired judgment, followed by renewed depression. That is the nature of rapid cycling bipolar disorder, and it is exactly why this condition is so profoundly disabling.
PHP/IOP Treatment: The Evidence MetLife Used Against Our Client
A Partial Hospitalization Program, or PHP, is a structured psychiatric treatment program that typically involves six hours of therapy per day, five days per week. An Intensive Outpatient Program, or IOP, is a step down from PHP, usually involving three hours of therapy per day. Both are reserved for patients whose psychiatric symptoms are too severe to be managed through routine outpatient care — they represent a level of treatment intensity just below inpatient hospitalization.
Our client participated in both. She was admitted to IOP in late 2024 and stepped up to PHP within weeks when her symptoms required more intensive intervention. She participated in cognitive behavioral therapy, dialectical behavior therapy, process groups, and psychoeducational groups while receiving weekly medication management. This was not optional wellness programming — it was clinically necessary psychiatric treatment for a patient in crisis.
MetLife, however, treated the completion of this treatment as evidence that our client had recovered. When she was discharged from IOP, MetLife used that date as the cutoff for benefits — as if completing a treatment program means the condition has resolved. But her discharge evaluation told a different story entirely. At discharge, her PHQ-9 score was 16 — still in the moderate depression range — and her GAD-7 score remained at 21, the maximum possible severity for anxiety. She was tearful during the discharge evaluation and described her mood as anxious. Her treating nurse practitioner documented that our client “just does not feel like she has gotten the results and help that she feels she needed to better manage her symptoms and her bipolar disorder.”
These are not the scores or observations of someone who is ready to return to a high-stakes professional role. They are the scores of someone who remains significantly symptomatic despite months of intensive treatment.
The Appeal: Connecting Psychiatric Instability to Occupational Demands
Attorney Jason Macri assembled a comprehensive appeal that attacked MetLife’s denial on multiple fronts. The appeal was built on a fundamental principle that MetLife had ignored: disability is not just about whether symptoms exist — it is about whether those symptoms prevent a specific person from performing the specific demands of their specific occupation.
Our client’s occupation as a Senior Technical Product Manager at Visa was a sedentary-level position — classified under the Dictionary of Occupational Titles as work performed primarily while sitting, with occasional walking and standing and lifting of no more than 10 pounds. But sedentary does not mean easy. The role required sustained cognitive stamina, precise decision-making under pressure, emotional regulation in professional interactions, the ability to manage complex technical projects across teams, and consistent executive functioning throughout each workday. MetLife conducted no analysis of whether our client’s documented psychiatric symptoms — impaired concentration, emotional dysregulation, pressured speech, mania-impaired judgment, repetitive thought patterns, and persistent sleep disruption — were compatible with these demands.
Challenging MetLife’s Use of Daily Activities as Evidence of Work Capacity
The appeal directly confronted MetLife’s reliance on our client’s job search activity, interviews, and travel considerations as evidence she could work. Attorney Macri argued that these sporadic, non-sustained activities bear no resemblance to the ability to meet the rigorous executive functioning demands of a full-time technical management role. Searching for a job from home, sitting through a brief interview, or considering future travel plans does not demonstrate the capacity to manage complex projects, regulate emotions in professional settings, maintain sustained concentration for eight hours a day, or exercise reliable judgment under pressure — day after day, week after week.
Reframing the Documentation Gap
The appeal also addressed MetLife’s argument that the absence of treatment records after discharge proved recovery. Attorney Macri documented that our client had lost her health insurance coverage, which created a gap in care that had nothing to do with clinical improvement. Her insurance carrier had initially refused to authorize the higher level of care her providers recommended, and by the time escalation was warranted, coverage had lapsed entirely. When she was able to re-establish care months later, her new providers documented the same symptoms — pressured speech, distractible concentration, depressed and anxious affect — confirming that the condition had never resolved.
Under the Employee Retirement Income Security Act of 1974, or ERISA, claimants in employer-sponsored group disability plans have 180 days from the date of a denial letter to file an administrative appeal. This appeal is the claimant’s only opportunity to build the administrative record — every piece of evidence, every medical record, every argument must be submitted during this window, because if the appeal is denied and a lawsuit follows, the court will generally review only the evidence that was before the insurer at the time of its decision. That is why the quality and comprehensiveness of the appeal matters so much.
Medication Intolerance as Evidence of Ongoing Disability
One of the most powerful elements of this appeal was the documented pattern of medication intolerance. Our client cycled through a striking number of psychiatric medications, each producing either intolerable side effects or inadequate therapeutic response:
- Seroquel (quetiapine) — caused muscle stiffness and restlessness, had to be discontinued
- Zyprexa (olanzapine) — same muscle stiffness and restlessness as Seroquel, discontinued after three days
- Abilify (aripiprazole) — helped with sleep but caused significant brain fog and lack of focus
- Fanapt (iloperidone) — recommended but denied by insurance; never obtained
- Prozac (fluoxetine) — made her feel edgy and anxious, dose increases worsened symptoms
- Lexapro (escitalopram) — caused extreme drowsiness and weight gain
- Zoloft (sertraline) — improved mood but triggered manic episodes
- Vraylar (cariprazine) — produced significant pacing and muscle pain
- Lurasidone — trialed as the next option after Vraylar failed
This is not a list of treatments that did not work out. This is a clinical trajectory that demonstrates treatment-resistant bipolar disorder — a condition so severe that the standard pharmacological interventions either failed or produced side effects that were themselves disabling. When an insurer argues that psychiatric symptoms are not severe enough to justify restrictions and limitations, a medication history like this is among the strongest evidence to the contrary. We have seen this same pattern in other MetLife cases, including one where MetLife attempted to impose a 24-month mental health limitation on a financial advisor’s claim, a denial we also reversed on appeal.
MetLife Reverses Its Decision
After reviewing the appeal submitted by attorney Jason Macri, MetLife reversed its decision to terminate our client’s long-term disability benefits. MetLife’s appeals department notified our office that it had “changed our original decision” and forwarded the claim to the Claims Specialist for reinstatement of benefits, including all back benefits owed.
This outcome was not a matter of luck or timing. It was the direct result of an appeal that assembled records from every treating provider, connected each clinical finding to the specific cognitive and emotional demands of our client’s occupation, documented the insurance coverage gap that MetLife had mischaracterized as clinical improvement, and built an undeniable medication history that proved the severity and treatment-resistance of her condition. We have achieved similar results in other MetLife appeals involving psychiatric conditions, including a case where we proved a contracts manager’s cognitive impairment warranted continued MetLife benefits despite the company’s denial, and a case where we demonstrated that a former Morgan Stanley employee’s ERISA claim for mental health disability benefits should never have been terminated.
Denied by MetLife or Another Disability Insurance Company?
If MetLife or any other disability insurance company has denied or terminated your long-term disability benefits, do not wait. Under ERISA, you have just 180 days to file an appeal, and the evidence you submit during that window may be the only evidence a court will ever consider. Every day that passes without action is a day the insurer uses to solidify its denial.
As attorney Macri wrote in the appeal, “absence of records is not evidence of recovery.” If your insurer is using a paper review, a gap in treatment, or your daily activities to justify cutting you off, that is exactly the kind of denial our office is built to fight.
Speak with one of our disability insurance attorneys for a free legal review of your claim. We represent claimants in every state, and you pay no fee unless we recover your benefits. Established in 1979, our firm has helped tens of thousands of claimants and recovered more than $2 billion in disability insurance benefits. We know how MetLife builds its denials, and we know how to take them apart.
